Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Humanities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
73
Search:
'"Humanities"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
2
Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
3
Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
4
Human growth hormone treatment for adult growth hormone deficiency : a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
Published 2015
CADTH Rapid Response Service
Subjects:
“
...
Human
Growth Hormone / deficiency...
”
Read Now
5
Human growth hormone treatment for adult growth hormone deficiency : a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
Published 2015
CADTH Rapid Response Service
Subjects:
“
...
Human
Growth Hormone / deficiency...
”
Read Now
6
Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
7
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
8
Pharmacoeconomic review report: Sarilumab (Kevzara)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
9
The use of antivirals for influenza prophylaxis : a review of the clinical effectiveness
by
Chao, Yi-Sheng
,
Spry, Carolyn
Published 2017
CADTH
Subjects:
“
...Influenza,
Human
/ immunology...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
13
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : for the treatment of adult patients with active ankylosing spondylitis who have responded inadequa...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
14
Pharmacoeconomic review report: Ixekizumab (Taltz)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
15
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
16
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
17
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
18
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
19
Ixekizumab (Taltz)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
Read Now
20
Ixekizumab (Taltz)
Published 2017
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ adverse effects...
”
1
2
3
4
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
73
610 - Medicine & health
25
330 - Economics
22
700 - The arts; fine & decorative arts
18
Language
English
73
Collection
National Center for Biotechnology Information
73
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
12
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
9
Chao, Yi-Sheng
3
Spry, Carolyn
3
Campbell, Kaitryn
2
more ...
Gray, Casey
2
Grobelna, Aleksandra
2
Picheca, Lory
2
Seal, Kelsey
2
Wells, Charlotte
2
Williams, D.
2
Young, Calvin
2
Adcock, Lorna
1
Argáez, Charlene
1
Edge, Rob
1
La Fleur, Philip
1
Marchand, Dave K.
1
Multiple Sclerosis Society of Canada
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22Humanities%22&type=Subject
Send by Email
×
Loading...